Introduction
Early observations of the hematovascular system Study of the hematopoietic system has historically been difficult because of its complexity. The majority of differentiated blood cells exist in circulation, while the progenitors generally remain within their niche. In vertebrates, the origins of the hematopoietic tissue are nonsingular, with a shifting source and localization over time. In total, the hematopoietic system is comprised of hematopoietic stem cells (HSCs), multiple terminally differentiated lineages, and multiple intermediate committed progenitors. The mouse model has allowed for the biological manipulation of the varied components that comprise the hematopoietic system using genetic approaches, transplantation, and lineage-tracing.
Initial studies seeking to define the origin of the hematovascular system were performed at the turn of the century.
Foremost was the work of Francis Sabin using chick hanging drop experiments, which allowed for direct visualization of the area pellucida as the hematovascular system was being formed [1] . The direct observation of a population of cells that appeared to arise from the mesoderm and were distinctly identified by their increased granularity and refractive properties were termed ''angioblasts'' because they expanded and comprised a vascular network [1] . After the subsequent aggregation of these angioblasts, the appearance of vacuoles was noted and thought to serve a role in the eventual appearance of centralized blood cells (altogether termed blood islands), suggesting to the observer that the hematovascular system originated from blood-island producing angioblasts [1] . The change from a mesodermal cell into a ''stem'' or ''mother'' cell was postulated to be the origin of the entire hematopoietic system [2] . The blood island aggregates were not only noted in the yolk sac but also within the major embryonic vessels of the chick [1] as well as within mammalian models including the pig, rabbit, and mouse [3] . Later observers of this phenomenon would coin the term hemangioblasts when referring to the blood-island forming angioblasts [4] . Although many of these seminal observations were made in the avian species, use of mus musculus was quickly adopted by hematologists due to its closer evolutionary relationship to humans, ease of culture and utility, and eventually due to its genetic accessibility. Although many of the initial observations of the hematopoietic system were made in the early 1900s, the elucidation of blood as a single stem cell derived lineage was not made until the 1960s via mouse transplantation models (Fig. 1) .
Transplantation
Identification and functional analysis of hematopoietic stem cells The postulation that the bone marrow was the seed-tissue of the hematopoietic lineage dates back to 1866 [5] . However, it wasn't until our understanding of irradiation and anemia that a test was developed to assess whether a specific site was responsible for maintaining the hematopoietic system. In 1951, it was noted that anemia after irradiation could be mitigated by protecting the spleen with a lead shield [6] . In the same year, transplantation of bone marrow cells was demonstrated to rescue irradiation lethality in mice and guinea pigs [7] . The transplantation study was the first to detail the use of cell suspensions, suggesting against the possibility that previous rescue or shielding experiments were due to a ''humoral'' factor [7] . To further the cellular hypothesis, transplanted bone marrow from a mouse line heterozygous for a distinct translocation demonstrated cellular repopulation was due to cell engraftment and not humoral factors [8] . It was demonstrated shortly thereafter that repopulation occurs in a dose-dependent (cell number) manner [9] . It was also demonstrated that frozen marrow could protect against radiation lethality [10] .
The first reports to recognize the existence of a HSC comprise a landmark body of work by Till and McCulloch [11] [12] [13] [14] [15] , published between 1963-1964. While earlier reports demonstrated the proliferative capacity of hematopoietic cells, the work of Till and McCulloch recognized the clonal repopulating activity of bone marrow that was transplanted into irradiated host mice. The experiments showed that mice that are subjected to a lethal dose of x-ray radiation are rescued by clonal expansion of donated bone marrow [11] . This was done by cytological analyses of spleen colonies that form upon transplantation. When bone marrow Figure 1 . Contributions to hematopoietic biology. A spiral timeline of major contributions the mouse system has made to our understanding of hematopoiesis. From early transplantation and clonal analyses to transgenic technology and future advancements, the mouse system has served as a critical model for hematopoietic biology. cells are introduced into irradiated host mice, viable progenitor cells can populate the spleen and contribute to hematopoiesis. This assay allows for the macroscopic colonies to be easily counted. Today it is known as the colony forming unit-spleen (CFU-S) assay, which is a quantitative readout for repopulating activity. It was discovered that rare cytologic abnormalities could be seen in a subset of spleen colonies that were unique among colonies but shared among all cells within the colony, strongly suggesting a clonal origin of the hematopoietic colony [11] . By comparing the number of bone marrow cells transplanted to the number of splenic colonies, a tight correlation between the two was shown. Following up this study, further investigations by Till and McCulloch demonstrated the self-renewal capacity of HSCs by serially transplanting cells from the bone marrow and formed splenic colonies, and they showed that the colony forming units decline in their ability to repopulate irradiated hosts after serial transplantations [12] . In 1969, the group published their work on transplantation of bone marrow cells after separation using sedimentation though serum gradients. By showing that repopulating activity peaked within a certain fraction using velocity sedimentation to physically separate cells by size, the group highlighted the heterogeneity of bone marrow and supported the notion of a distinct set of stem cells [16] . This allowed for the development of competitive repopulation assays where competing bone marrow subsets from two separate hosts with distinguishable hemoglobin profiles are transplanted [17] , allowing for the evaluation of HSC long-term function comparisons across mouse lines. The in vivo clonal analysis of the CFU-S led to its in vitro derivative, the colony forming unit-culture (CFU-C), a robust in vitro assay that is still relied upon today for in vitro functional analysis. One of the first clonal in vitro differentiation assays was devised by Pluznick and Sachs in 1965, where granulocyte colonies could be cultured and different organs could be assayed for their ''mast'' cell content [18] . Mouse bone marrow was then also noted to form colonies in vitro using feeder layers [19] , which proposed the existence of hematopoietic maturation factors, termed ''colony stimulating factors'' [20] .
A decade later, cell sorting and analysis technology ushered in the identification and functional analyses of hematopoietic subsets. A series of landmark reports [21] [22] [23] [24] utilized a relatively new blend of technologiesdthe use of cellsurface antibodies and fluorescence-activated cell sorting with transplantation. Weissman et al [21] demonstrated that Thy-1 lo Lin À Sca-1 þ cells had multilineage repopulation capacity in transplanted host animals. They provided three major breakthroughs for the field. They described a cell-surface antigen profile of HSC subsets, in which HSCs could be sorted and seeded into a host, and irrefutable evidence of a self-renewable HSC pool. They further demonstrated that this population of bone marrow HSCs was the only population with the capacity to rescue the host mouse, self-renew, and repopulate the hematopoietic system of the organism [25] . The group also demonstrated the multilineage repopulating capacity of the HSC subset using limiting dilution and antigen-tracing techniques [26] .
The defined HSC marker set was then expanded to include the signaling lymphocyte activation molecule (SLAM) family receptor CD150, discovered through gene expression profiling of sorted HSCs [27] . Furthermore, HSCs could be distinguished from progenitor populations through expression of different SLAM receptors (CD150, CD244, and CD48) [27] . The new surface marker repertoire for HSCs indicated that there may be further refinement of markers that can detect HSCs uniquely and that the current criteria for sorting HSCs may be further simplified. Despite having a welldefined marker set, it is noted that individual HSCs do not contribute to all lineages in constant proportions. There have been multiple reports using single-cell lineage transplantation, which indicate individual HSCs isolated from bone marrow may have distinct and unique lineage contributions from another isolated in the same pool [28, 29] . Thus, while transplantation has allowed the identification of HSCs and the refinement of surface markers to detect them, HSCs are in themselves a heterogeneous population, as recently demonstrated by single-cell clonal transplantation analysis [30] and a new technique of cellular barcoding [31, 32] . In addition, recent studies suggest in addition to lymphoid-or myeloid-biased HSCs [33] , there may also be long term progenitor populations that self-renew [30] .
Developmental origin of HSCs
Many embryonic and fetal tissues have been found to contain hematopoietic cells capable of reconstitution of irradiated adult hosts. It was previously shown by multiple groups that both the yolk sac and fetal liver have the capacity to produce CFU-S colonies [34, 35] . As the earliest appearance of blood cells (nucleated erythrocytes) are located in the yolk sac blood islands, investigation into the onset of HSC development has focused on the hematopoietic capacity of this tissue. In addition, the assays used to distinguish the initial autonomous site of hematopoiesis within the embryo were near identical to those used in the adult murine system, namely the transplantation of irradiated adult hosts. In 1967, Moore and Owen [36] had initially evaluated the avian model using chromosome markers between male and female animals and irradiated embryos to demonstrate that yolk sac cells contributed to adult hematopoietic organs. However, it was observed that the contributions did not account for all the hematopoietic cells in the adult [36] . Moore and Metcalf [35] then expanded these studies to the murine system by transplanting yolk sac cells after 2-6 days culture, as well as fetal liver into irradiated adult hosts. It was noted the yolk sac after culture could reconstitute adult hosts beginning at 8 days of gestation, and that the fetal liver could begin reconstitution at day 10, which coincided with the reconstitution ability of circulating cells of the embryo [35] . In addition, when the 7-day embryo and yolk sac are cultured separately, the in vitro CFCs appear to exclusively reside in the yolk sac [35] . This set a paradigm where the first HSCs were thought to derive from yolk sac blood islands, then enter the circulation to take up residence in the fetal liver before finally populating the adult bone marrow.
This paradigm was challenged in 1975 by a seminal article using avian systems by Dieterlen-Lievre [37] , whose grafting experiments of chick yolk sacs to quail embryos demonstrated an intraembryonic source of the adult hematopoietic system. However, there was a lack of support for the model in murine systems. While the murine system had hithertofore been the defining system for hematopoietic ontological study, it had many drawbacks when compared with the avian system. In utero development makes the murine embryo inaccessible to direct manipulation for subsequent late-stage or adult analyses. In addition, its circulatory system connecting the embryo, yolk sac, and placental circulation makes the discrimination between sites of HSC origin and migration arduous. However, despite these challenges, support for a mammalian intraembryonic site of HSC origination was established in the early 1990s [38, 39] . The aorta, gonad, mesonephros (AGM) region was discovered to be the intraembryonic murine hematopoietic site analogous to that of the avian system [38] . It was demonstrated that the murine AGM had higher CFU-S capacity than the yolk sac or fetal liver [38] , and the CFU-S activity originates autonomously in the AGM region [39] . These studies were then supported by the detection of lymphoid and multilineage HSC activity in the embryonic paraaortic splanchnopleura (the precursor to the AGM) [40, 41] . Furthermore, when the yolk sac was separated from the embryo before circulation, the para-aortic splanchnopleura demonstrated lymphoid potential in vitro [42] and reconstitution capacity of irradiated adult hosts [43] , suggesting that akin to the avian species, the mammalian embryo body, and not the yolk sac, is the source for adult HSCs.
Thus, murine developmental sites of hematopoiesis were historically defined by long-term multilineage repopulation capability of adult hosts. It should be mentioned however that the heterochronic transplantation scheme has multiple drawbacks for developmental analyses. It assumes that repopulation activity is not observed in the host mouse because of cell-intrinsic properties, and also that the host is competent to receive the cell population. Moreover, there may exist HSCs in the early embryo that require maturation in developmental niches before acquiring the capacity of engrafting irradiated adult hosts. Using a newborn myeloablation model, yolk sac cells incapable of adult engraftment were demonstrated to be capable of long-term reconstitution in the newborn mouse [44, 45] . Furthermore, it was shown that bone marrow from these carrier pups could then be isolated and used to reconstitute irradiated adult mice [45] . Taken together, these results demonstrate that the embryonic yolk sac does have the capacity for multilineage long-term engraftment of a host mouse. Yet when the strict standard of reconstitution of adult hosts is applied, the earliest embryonic site capable of adult engraftment, using in vitro culture followed by transplantation, is the intraembryonic para-aortic splanchnopleura/AGM. The early yolk sac is then relegated to the source of a transient or ''primitive'' wave of hematopoiesis of erythroid progenitors, but it is also noted to be the source of multiple longterm lineages including macrophage and lymphoid populations and, later in development, multipotent HSCs [46] . In addition to the yolk sac, the placenta can also contribute significantly to the definitive HSC pool, as measured by transplantation assays [47, 48] . By E10.5-11.0, all hematopoietic regions in the embryodyolk sac, AGM, placenta, and fetal liverdcan reconstitute adult irradiated hosts. But because circulation is well established at that time, it is difficult to discern relative contributions. When isolated before circulation at E8.0, only the paraaortic splanchnopleura, after several days in culture, has been shown to engraft adult hosts.
The murine system as a functional assay for human hematopoiesis In addition to its critical role in our current understanding of mammalian developmental hematopoiesis and HSC biology, mouse models have also provided an invaluable resource in understanding human hematopoiesis by allowing functional assessment of human HSCs. Termed ''humanized mice,'' murine models have been established that allow xenografts of human cells into mice. As engraftment of human cells will not occur in standard mouse breeds due to immunological rejection, attenuated models were developed. One of the first reports of humanized mouse models noted that the scid/scid (Prkcd scid ) mouse strain, which lacks T and B cells and thus recapitulate severe combined immune deficiency (SCID), can be engrafted with human fetal thymus, liver, and lymph node cells (termed SCIDhu mice), resulting in the detection of human lymphoid cells within the mouse circulation [22] . The SCID-hu model then inspired subsequent investigation into immunodeficient mouse strains with the aim of improving human engraftment efficiency [49] . The most recent evolution of the model combines the nonobese diabetic (NOD)/severe combined immunodeficiency (SCID) strains with an IL2R-g c chain null mutant [50, 51] , and hence is referred to as the NOD/SCID IL2Rg (NOG or NSG) mouse line. The NSG line demonstrates robust engraftment efficiency when human cells are transplanted into newborn and adult NSG mice [50, 51] . Hence, the NSG mouse model has become an invaluable tool for multiple fields that include hematology, immunology, and virology (HIV has been studied in these lines dating back to the original SCID-hu model) [52] . The model is now considered the standard for functional evaluation of human hematopoietic populations.
Transgenics
Murine knockout models of primitive and definitive hematopoiesis While the concept of ''primitive'' hematopoiesis arose initially from morphological analyses of the first embryonic blood cells [46] , transplantation assays and the development of transgenic mouse models refined the characterization of primitive and definitive hematopoiesis. Expansion of the definition suggests that ''primitive'' represents a transient population not present in the adult, while HSCs that arise in the embryo and persist throughout adulthood are termed ''definitive''. Knockout (KO) technology in the mouse has enabled the study of specific genes involved in both primitive and definitive hematopoiesis. Evaluation of genetically engineered mice with homozygous loss of a specific gene helps determine how that gene may function and in which particular hematopoietic lineage. While the list of critical genetic KO mouse models is exhaustive and thoroughly reviewed elsewhere [53] , here we focus on a few of the key genes identified.
Early erythroid differentiation was shown to require the transcription factor GATA1 using genetic deletion in mouse ES cells [54] . It was demonstrated that Gata1-deficient cells in chimeric mice were unable to contribute to the erythroid lineage, affecting both primitive and definitive waves of hematopoiesis [54, 55] . Similarly, Gata2 knockout mice exhibit defects in primitive hematopoiesis, and Gata2 null cells do not contribute to definitive hematopoiesis in chimeras [56] . Both Gata1 and Gata2 knockouts result in embryonic lethality, and the two genes functionally overlap in primitive erythropoiesis [57] . However, Gata2 was also found to have a critical role in HSC maintenance and expansion [58] with gene dosage effects on HSC ontogeny in the AGM [59] . Insight into Gata2 regulation was recently made when GATA1 was demonstrated to bind upstream Gata2 locus sites, exerting a repressive role [60, 61] , while genetic deletion of a cis-acting element composed of an E-box and GATA motif proved critical for Gata2 function in the AGM [62] .
A putative target of GATA2 is SCL/tal1 [63] , a transcription factor known to be expressed in hematovascular tissues [64] that was first identified because of its translocation in human leukemia [65] . SCL/tal-1 knockout mice die after E10.5 with failure of yolk sac hematopoiesis [66] [67] [68] . Chimeric mice generated with scl null cells demonstrated that SCL/tal-1 is responsible for all cell contributions to definitive hematopoiesis, as no null cells were found within the chimera's hematopoietic system [66, 69] . SCL became of immense interest, as its loss of function phenotype and its expression pattern suggested that it lie at the top of a regulatory network necessary for the early hemangioblast specification and subsequent HSC function [70, 71] . Therefore, due to its function in both waves of hematopoiesis, SCL was considered a panhematopoietic gene. The advent of conditional gene deletion in mice would refine this definition, and will be discussed later in this section.
Runx1, formerly known as core-binding factor alpha 2 (Cbfa2), is another transcription factor discovered through its translocation in human leukemias, and is known as acute myeloid leukemia gene 1 (AML1). It demonstrates severe hematopoietic defects when deleted in vivo [72, 73] . The Runx1 knockout mouse was critical in providing evidence of a distinct definitive wave of hematopoiesis in vivo. Total loss of the Runx1 gene results in complete loss of definitive hematopoiesis with little or no defect in yolk sac primitive hematopoiesis [73, 74] . Due to its substantial requirement in definitive populations, expression patterns of Runx1 became of significant interest in developmental hematopoiesis. Runx1 was noted to be localized to the major arterial regions of the embryo and their associated clusters of rounded hematopoietic cells [74, 75] , which were described nearly a century prior [3] . Runx1 loss ablated the formation of arterial associated clusters [74, 75] ; hence, investigation ensued as to whether the endothelium, its underlying mesenchyme, or another population (possibly circulating hemangioblasts) gave rise to the early appearance of definitive Runx1 þ HSCs. It would not be an answerable question in the murine system without the development of new genetic tools that allowed for dissection of gene requirements within specific tissue compartments.
Compartment matters: Fate tracing, conditional, and timed conditional knockouts With the advent of Cre recombinase technology [76, 77] , gene function within a specific tissue compartment can be studied by expressing the bacteriophage enzyme Cre recombinase under the control of a tissue-specific promoter [78] . When crossed to a mouse line genetically engineered with the gene of interest flanked by loxP sites (floxed), the floxed gene segment is excised in tissues expressing the promoter driven Cre [78] . This extremely powerful tool has engendered groundbreaking discoveries in mammalian biology, as it combines the detailed genetic manipulation of lower vertebrate models with the murine in vivo mammalian system. Furthermore, alterations of the original technology have produced temporal genetic control via timed induction of Cre recombinase activity [79] . Timed induction is achieved with fusion of the Cre recombinase to a mutated estrogen receptor specific for synthetic estrogen analogues (tamoxifen) but not endogenous estrogen, termed CreER T [79] [80] [81] , and a subsequent generation CreER T2 [82, 83] . Another important adaptation of the Cre-Lox system is that of cellular fate tracing. Cre activity can be used to recombine a floxed stop codon upstream of a fluorescent reporter in a ubiquitously constitutively expressed locus, such as the ROSA26 locus [84] , allowing for the expression of the reporter [85] . With conditional and inducible genetic manipulation now available, multiple groups have revisited the original knockout data with a refined evaluation of tissue-specific and/or inducible genetic recombination, as well as the powerful tool of genetic fate tracing.
Understanding the origination site for definitive HSCs became possible using these powerful genetic tools in the murine system. Because previous work demonstrated that Runx1 was required for definitive HSCs, the Cre recombinase system was then used to specifically delete Runx1 in endothelial versus hematopoietic compartments [86, 87] . Using this targeted approach, it was demonstrated that the Runx1 requirement for HSC emergence is exclusive to the endothelial compartment [86] , lending credence to the notion of endothelial-derived hematopoiesis, e.g. hemogenic endothelium. The concept of hemogenic endothelium contrasts that of the hemangioblast, whereby the hemangioblast is a postulated bipotential mesodermal cell that gives rise to endothelium and blood in parallel, and hemogenic endothelium suggests an endothelial population specified from the mesoderm that directly produces blood cells. It is an important distinction when trying to understand how definitive HSCs are specified. The requirement of Runx1 in the endothelial compartment, in addition to endothelial fate tracing that demonstrated HSCs originate from endothelial compartments [88] , strongly suggest that definitive HSCs arise directly from hemogenic endothelium. These studies were later supported by in vitro live imaging of murine endothelium producing hematopoietic clusters [89, 90] . Inducible Cre technology was also used to fate trace early Runx1 þ cells in the embryo, whereby induction of Runx1 populations via a Runx1-Cre at E7.5 demonstrated fatemapped lineages in the adult bone marrow [91] . Early embryonic contributions to adult hematopoiesis were also supported by the use of circulation mutants. Ncx À/À embryos lack a functional circulation and under those conditions, the yolk sac, and separately the placenta, were demonstrated to harbor definitive HSCs [92, 93] .
Interestingly, while Runx1 is required in endothelial populations for HSC development [86] , HSCs then later function in a Runx1-independent fashion [87] . The stark contrast of phenotypes between total loss of gene function, suggesting ongoing requirements in HSCs, and conditional loss within the hematopoietic compartment, demonstrating only very early requirements, is not specific to Runx1. The critical hematopoietic transcription factor SCL/tal-1 demonstrates a similar lack of requirement after conditional loss in the hematopoietic compartment [94, 95] . Two groups using an Mx-Cre to delete SCL/tal1 in hematopoietic cells [94, 95] , noted a lack of any major effects on HSC function, despite data from scl -/-chimeras suggesting an scl requirement for all hematopoietic cells [66, 69] . Using a Tie2 Cre for induction of early endothelial populations, it was noted that fetal liver HSCs remained intact, suggesting that the requirement for SCL/tal-1 in HSC emergence was before or during Tie2 endothelial specification in the early embryo [96] . Timed loss of the SCL/tal-1 gene during early development (E6. 5-8.5) demonstrates that SCL serves to repress cardiogenesis in early mesoderm for specification of hemogenic endothelium [97] . Thus, many of the critical transcription factors for hematopoiesis uncovered by total gene loss seem to function very early in development. One exception is the transcription factor Gata2. Gata2 tissue-specific deletion in both endothelial and hematopoietic compartments, using a VE-cadherin Cre and Vav-Cre respectively, demonstrates its universal requirement for HSC emergence and survival [98, 99] . Thus much like the total loss of Gata2 function [56] , conditional studies demonstrated that Gata2 is a regulator of the HSC population throughout development.
While HSCs and hematopoietic progenitor cells are functionally assessed by transplantation and in vitro colony-forming assays, the combination of these tools with transgenic mouse technology has uncovered their coexistence and coemergence in the embryo. For example, CBFb À/À mutants (CBFb is a Runx1 binding partner) display significant hematopoietic defects [100] . Rescue of mutants by expression of CBFb under the endothelialspecific promoter Tek, or Tie2, favors the generation of erythroid or myeloid progenitors [101] . However, CBFb expression from the Ly6a (Sca-1) promoter, favors the generation of bona fide HSCs [101] , suggesting that the emergence of hematopoietic progenitors and HSCs can be uncoupled even when both populations have similar gene requirements. As technological advancements are made within the murine system, the true complexity of hematopoietic emergence and differentiation can be further elucidated.
Conclusions

Caveats
We have touched upon the major advances in mouse models allowing for timed-and tissue-specific deletion, as well as the historical importance of mouse transplantation models in HSC biology. However, many of the new advances highlighted are not without caveats. Tissuespecific Cre induction is entirely dependent on the promoter activity and specificity that drives the Cre recombinase gene. Hence when making conclusions about fate tracing or gene function, it is crucial to account for all populations that may activate the promoter in both physiological and pathological states. Timed conditional Cre models introduce an added variable of tamoxifen kinetics. Developmental windows of hematopoietic sites are quite narrow as the AGM, yolk sac, placenta, and fetal liver all have overlapping periods of HSC activity. Tamoxifen levels tend to peak in adult murine sera within 24 hours of administration by intraperitoneal injection and can linger at levels shown to activate CRE-ER T in culture [80, 82] for at least 48-72 hours [88] . In addition, the efficiency of Cre recombinase to excise a particular flanked genetic sequence also varies significantly [102] . Other models of timed gene regulation in the murine system include the tet-on/off systems that allow for tetracycline inducible transcriptional control of genetic expression [103] . Although the inducible mouse models differ in their regulation, they have the similar caveats of reliance on promoters and pharmacologic agents for control. As mentioned previously, transplantation assays are not also without drawbacks, especially for the developmental system. Early pre-HSC populations may be incapable of engrafting an irradiated adult, but they may be competent to become an adult HSC when allowed to physiologically mature in its own host. In addition, adult HSC engraftment may signify a different functional ability of donor cells in a unique pathologic environment.
Mouse models of the future Given the caveats of the current models, it is not surprising that newer technologies are being adapted to the mouse system for improved genetic control. One such system that is rapidly being adopted is the CRISPR/Cas9 genome editing system [104] [105] [106] . The bacterial system is comprised of a Cas9 nuclease that can be guided to a particular sequence in the genome for the generation of mouse lines with point mutations, deletions, conditional deletion, or reporter expression [106] , or multiplexed for manipulations of multiple genes at once [104, 105] . In addition, the system can be used for large-scale gene silencing (CRISPRi) [107] [108] [109] . While the CRISPR/Cas9 system now allows generation of more complex genetically engineered mouse lines, it would be ideal to harness the multiple applications of the system for spatial and temporal control. Its current promise for multiple genetic modifications in a single mouse line can allow for the investigation of multiple related or unrelated hematopoietic genes within the same organism. In addition, human genetic mutations can be recapitulated in the murine system to understand how a particular mutation impacts hematopoietic development and function in the animal. Downstream genetic analyses of hematopoietic subsets have also become more robust with the advent of highthroughput sequencing. Sequencing at the single cell level combined with genetic barcoding (the generation of uniquely marked single cells) is an extremely powerful tool for understanding single cell and population dynamics, progeny, and fate. DNA barcoding allows for clonal analyses in vivo. Using retroviral libraries with unique sequence tags (barcodes), HSCs are transduced and then transplanted with subsequent evaluation [31, 110] . While this can only currently be done in isolated cell populations with subsequent transduction and transplantation, one could imagine future mouse models that may allow for tissue-or time-specific integration of barcodes for in vivo analyses. The murine system has allowed enormous advancement in our understanding of hematopoiesis and HSC biology, and with the rapid development of new technologies and adaptation into the mouse system, it will likely serve as a compelling model system well into the foreseeable future.
